Inventor
GERE S. DIZEREGA
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61BDiagnosis13%
C07KPeptides13%
Y02ATechnologies for adaptation to climate change13%
PatentTitleYear
12,329,858Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer202512,128,131Treatment of epithelial cysts by intracystic injection of antineoplastic particles202411,918,691Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer202411,737,972Treatment of epithelial cysts by intracystic injection of antineoplastic particles202311,583,499Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer202311,523,983Treatment of epithelial cysts by intracystic injection of antineoplastic particles202211,160,754Methods for treating lung disorders2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to CRITITECH INC (7)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CRITITECH INC | 7 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2025 |